| Leistung |
Fallzahl |
OPS-Schlüssel |
Info |
|
415
|
9-696.40 |
|
| Regelbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Kindern und Jugendlichen |
309
|
9-656 |
|
|
251
|
9-696.52 |
|
|
162
|
9-696.55 |
|
|
145
|
9-696.35 |
|
|
143
|
9-696.38 |
|
|
126
|
9-696.51 |
|
|
116
|
9-696.37 |
|
|
115
|
9-696.39 |
|
|
104
|
9-696.54 |
|
|
102
|
9-696.36 |
|
|
96
|
9-696.3a |
|
|
93
|
9-696.3b |
|
|
92
|
9-696.58 |
|
|
83
|
9-696.34 |
|
|
83
|
9-696.41 |
|
|
81
|
9-696.53 |
|
|
81
|
9-696.5b |
|
|
73
|
9-696.57 |
|
|
68
|
9-696.32 |
|
|
67
|
9-696.33 |
|
|
67
|
9-696.56 |
|
|
66
|
9-696.10 |
|
|
66
|
9-696.3c |
|
|
64
|
9-696.11 |
|
|
53
|
9-696.0 |
|
|
51
|
9-696.59 |
|
|
49
|
9-696.12 |
|
|
49
|
9-696.13 |
|
|
44
|
9-696.31 |
|
|
41
|
9-696.17 |
|
|
40
|
9-696.3d |
|
|
40
|
9-696.5a |
|
|
37
|
9-696.16 |
|
|
36
|
9-984.8 |
|
|
35
|
9-696.50 |
|
|
34
|
9-696.5c |
|
|
32
|
9-696.3g |
|
|
32
|
9-696.5d |
|
|
32
|
9-984.7 |
|
|
31
|
9-696.18 |
|
| Psychiatrisch-psychosomatische Intensivbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Kindern und Jugendlichen |
29
|
9-672 |
|
|
28
|
9-696.19 |
|
|
28
|
9-696.3e |
|
|
26
|
9-696.1a |
|
|
24
|
9-696.14 |
|
|
22
|
9-696.15 |
|
|
21
|
9-696.5e |
|
|
18
|
9-696.30 |
|
|
18
|
9-696.3f |
|
|
17
|
9-696.1b |
|
| Audiometrie |
16
|
1-242 |
|
|
16
|
1-945.0 |
|
|
15
|
9-64a.4 |
|
|
15
|
9-64a.6 |
|
|
15
|
9-64a.7 |
|
|
15
|
9-696.42 |
|
|
14
|
9-696.1c |
|
|
14
|
9-984.b |
|
|
13
|
9-984.9 |
|
| Elektroenzephalographie [EEG]: Routine-EEG (10/20 Elektroden) |
12
|
1-207.0 |
|
|
12
|
9-64a.3 |
|
|
12
|
9-64a.5 |
|
|
12
|
9-696.5f |
|
|
10
|
9-696.5g |
|
| Phoniatrie |
9
|
1-243 |
|
|
9
|
9-696.1d |
|
|
8
|
1-945.1 |
|
|
8
|
9-696.5k |
|
|
7
|
9-64a.2 |
|
|
7
|
9-696.21 |
|
|
6
|
9-696.20 |
|
|
6
|
9-696.5j |
|
|
6
|
9-696.5m |
|
|
6
|
9-984.6 |
|
|
4
|
9-64a.1 |
|
|
4
|
9-696.1e |
|
|
4
|
9-696.5q |
|
|
4
|
9-696.5u |
|
| Elektroenzephalographie [EEG]: Schlaf-EEG (10/20 Elektroden) |
k.A.
|
1-207.1 |
|
| Applikation von Medikamenten, Liste 2: Etanercept, parenteral: 125 mg bis unter 150 mg 125 mg bis unter 150 mg |
k.A.
|
6-002.b4 |
|
| Therapie organischer und funktioneller Störungen der Sprache, des Sprechens, der Stimme und des Schluckens |
k.A.
|
9-320 |
|
|
k.A.
|
9-696.1f |
|
|
k.A.
|
9-696.1g |
|
|
k.A.
|
9-696.43 |
|
|
k.A.
|
9-696.5h |
|
|
k.A.
|
9-696.5n |
|
|
k.A.
|
9-696.5p |
|
|
k.A.
|
9-696.5s |
|
|
k.A.
|
9-696.5v |
|
|
k.A.
|
9-984.a |
|
